首页> 外国专利> Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo

Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo

机译:用于评估CRISPR / CAS介导的破坏或切除和CRISPR / CAS诱导的重组的方法和组合物与体内外源供体核酸的重组

摘要

Methods and compositions are provided for assessing CRISPR/Cas-mediated non-homologous end joining (NHEJ) activity and/or CRISPR/Cas-induced recombination of a target genomic locus with an exogenous donor nucleic acid in vivo or ex vivo. The methods and compositions employ non-human animals comprising a CRISPR reporter such as a genomically integrated CRISPR reporter for detecting and measuring targeted excision of a sequence between two CRISPR/Cas nuclease cleavage sites or disruption of a sequence near a CRISPR/Cas nuclease cleavage site and/or measuring CRISPR/Cas-induced recombination of the CRISPR reporter with an exogenous donor nucleic acid to convert the coding sequence for a first reporter protein to the coding sequence for a different second reporter protein. Methods and compositions are also provided for making and using these non-human animals.
机译:提供了用于评估CRISPR / CAS介导的非同源末端接合(NHEJ)活性和/或CRISPR / CAS诱导的靶基因组基因座的重组与体内的外源供体核酸的方法和组合物。方法和组合物使用包含Crispr报道的非人动物,例如基因组综合的CrispReper,用于检测和测量两种CRAP / CAS核酸酶切割位点之间的序列的序列的序列的序列,或者在CRAP / CAS核酸酶切割位点附近的序列中的破坏和/或测量CRISPR / CAS诱导的CRISPR记者用外源供体核酸重组,以将第一报告蛋白的编码序列转化为不同的第二报告蛋白的编码序列。还提供了制备和使用这些非人动物的方法和组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号